What's Happening?
The PRIMA wireless retinal implant, designed to restore functional vision in people with geographic atrophy, has received CE marking, allowing its sale across 30 European countries. Developed by Science Corp., the implant is intended for patients with advanced
dry age-related macular degeneration (AMD), a condition that affects over five million people worldwide. The implant works by using a chip placed beneath the damaged retina, which receives processed images from specialized glasses and stimulates retinal cells to restore vision. The approval follows successful trials where 81% of participants showed significant improvement in vision. The system does not restore normal eyesight but offers a significant improvement for those affected by AMD.
Why It's Important?
The approval of the PRIMA implant is a major advancement in the treatment of geographic atrophy, offering hope to millions affected by this form of AMD. By restoring functional vision, the implant can significantly improve the quality of life for patients who would otherwise face progressive vision loss. The technology represents a breakthrough in medical devices, utilizing advanced optics and electronics to bypass damaged retinal cells. This development could pave the way for similar innovations in treating other forms of vision impairment. The approval in Europe also sets a precedent for potential regulatory acceptance in other regions, including the United States, where the device has been granted Breakthrough Device status by the FDA.
What's Next?
Following the CE marking, Science Corp. plans to activate surgical centers and train medical teams across Europe to begin commercial implantations. The company is also working on securing reimbursement from national health systems and insurers. In the United States, Science Corp. aims to obtain a Humanitarian Device Exemption to market PRIMA for specific conditions. The success of these efforts will determine the widespread availability of the implant and its impact on the global market for vision restoration technologies.
